SBI Life Insurance Company Ltd Analyst Rating
based on 32 analysts
93.75%
Buy
6.25%
Hold
0.00%
Sell
Based on 32 analysts offering long term price targets for SBI Life Insurance Company Ltd. An average target of ₹1988.19
Source: S&P Global Market Intelligence
SBI Life Insurance Company Ltd Share analysis
SBI Life Insurance Company Ltd price forecast by 32 analysts
Upside of41.42%
High
₹2500
Target
₹1988.19
Low
₹1700
SBI Life Insurance Company Ltd target price ₹1988.19, a slight upside of 41.42% compared to current price of ₹1400.6. According to 32 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
SBI Life Insurance Company Ltd revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
SBI Life Insurance Company Ltd EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
SBI Life Insurance Company Ltd Performance
Day's Low
Day's High
₹1,391.1Day's Price Range₹1,414.852 Week's Low
52 Week's High
₹1,307.752-Week Price Range₹1,936
| Returns % | |
| 1 Month Return | -4.87 % |
| 3 Month Return | -26.78 % |
| 1 Year Return | + 0.15 % |
| Market Stats | |
| Previous Close | ₹1,405.90 |
| Open | ₹1,402.45 |
| Volume | 15.43L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,40,085.90Cr |
SBI Life Insurance Company Ltd Key Statistics
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Market Cap | ₹1,40,085.90 Cr |
| P/B Ratio | 10.06 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Insurance |
| ROE | 12.14 |
SBI Life Insurance Company Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹1,40,085.90 Cr | 8.21% | 0.98 | NA | NA | |
| BUY | ₹92,819.00 Cr | 6.93% | 0.53 | NA | NA | |
| BUY | ₹95,751.69 Cr | 6.23% | 0.98 | ₹850 Cr | ₹89,683 Cr | |
| BUY | ₹1,34,437.00 Cr | 0.24% | 0.98 | ₹1,574 Cr | ₹1,01,481 Cr | |
| BUY | ₹5,73,329.42 Cr | 0.68% | 0.99 | ₹40,915 Cr | ₹8,45,966 Cr |
SBI Life Insurance Company Ltd Mutual Fund Holdings
About SBI Life Insurance Company Ltd
SBI Life Insurance's top products include term insurance plans, endowment plans, pension plans, children's plans, ULIPs, and group insurance plans. Its popular brands include Smart Shield, Smart Elite, Saral Jeevan Bima, and Grameen Bima. SBI Life Insurance also offers a range of rider benefits such as accidental death benefit, critical illness benefit, and waiver of premium benefit. SBI Life Insurance has a strong customer base with over 1.5 crore policyholders and a network of over 1,000 branches.
Share Price: ₹1400.60 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹1,40,085.90Cr as of today
Listing date: 03 Oct, 2017
Chairperson Name: DINESH KUMAR KHARA
| Organisation | SBI Life Insurance Company Ltd |
| Headquarters | Mumbai |
| Industry | Insurance |
| E-voting on shares | Click here to vote |
Key events for SBI Life Insurance Company Ltd
SBI Life Highlights Financial Security and Equity Allotment - 17 Dec, 2024
SBI Life Insurance Company launched a TVC campaign focusing on financial security's importance in fulfilling aspirations. Additionally, the company allotted 43,966 equity shares under its Employee Stock Option Scheme, enhancing its paid-up capital.SBI Life Insurance Shifts Focus to Non-Linked Products - 15 Dec, 2024
SBI Life Insurance's MD & CEO Amit Jhingran highlights a shift towards non-linked products amid equity volatility. The company launched SBI Life Smart Platina Supreme, catering to the younger demographic's need for guaranteed income and future planning.SBI Life Insurance Stock Target Price Set - 06 Dec, 2024
SBI Life Insurance Company Ltd is currently trading at Rs 1,448.55, with a target price of Rs 1,557 and recommended entry price range of Rs 1,435 to Rs 1,449.SBI Life Shares Decline Amid Regulatory Concerns - 29 Nov, 2024
On November 29, SBI Life Insurance shares dropped 1.70% amid concerns over potential IRDAI regulatory changes affecting bancassurance. The company clarified no discussions on revisions occurred.SBI Life Shares Decline Amid Bancassurance Concerns - 28 Nov, 2024
SBI Life Insurance faced a significant decline in shares due to reports of potential IRDAI caps on bancassurance sales. The company and Max Life denied any regulatory discussions on this matter, emphasizing their commitment to diverse distribution models.SBI Life Reports Strong Growth and Buy Recommendation - 27 Nov, 2024
SBI Life Insurance Company reported a significant increase in net sales and profit for September 2024. ICICI Securities issued a buy recommendation with a target price of Rs 1,978, highlighting attractive valuations and growth potential.SBI Life Insurance Market Cap Declines Amid Volatility - 21 Nov, 2024
SBI Life Insurance's stock price fell by 2.78% to Rs 1,480.50, resulting in a market cap loss of Rs 4,252 crore. The decline reflects cautious investor sentiment in the volatile life insurance sector.SBI Life Shares Decline Amid Market Concerns - 19 Nov, 2024
On November 19, 2024, SBI Life Insurance shares fell nearly 3%, resulting in a market cap loss of Rs 4,653 crore, influenced by regulatory comments and cautious sector outlooks.SBI Life Insurance Maintains Buy Rating with Target Price - 18 Nov, 2024
SBI Life Insurance Company reported a 39.3% YoY increase in PAT for Q2FY25, driven by operational efficiencies. Despite a decline in single premiums, first-year and renewal premiums grew. The company maintains a BUY rating with a revised target price of Rs. 1,748, based on strong fundamentals and growth in assets under management.
Insights on SBI Life Insurance Company Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 24.71% to 25.19% in Sep 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 3.99% to 4.10% in Sep 2024 quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, SBILIFE has outperformed top 5 stocks with highest market-cap in Life & Health Insurance
NO EFFECTAgainst Peers
In the last 1 year, ICICI Prudential Life Insurance Company Ltd has given 27.4% return, outperforming this stock by 29.3%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 55.41% to 55.39% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 12.76% to 12.19% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, SBILIFE stock has moved down by -8.2%
News
Factors Behind the Rise in Dr Reddys Share Price
Recently, Dr Reddys share price has gained significant attention. Over the last five days, its share price surged 7.6%. Dr Reddys Laboratories is gaining attention due to its strategic focus on long-term growth and emerging markets. Despite underperforming against the Nifty Pharma Index over the last 1-5 years, international brokerage firms have upgraded their price targets for the company. This upgrade indicates confidence in Dr Reddys ability to overcome near-term hurdles and leverage future growth opportunities. The stocks recent challenges stem from heavy dependence on gRevlimid, whose sales are expected to decline by FY26, and increased overheads linked to rising investments in R&D, biosimilar trials, and manufacturing upgrades. These investments have led to temporary pressure on profit margins. For instance, earnings before interest, tax, depreciation, and amortisation (EBITDA) margins are forecasted to remain slightly under the pressure through FY27. However, analysts project accelerated earnings growth starting FY28 as new revenue streams such as GLP-1 APIs, biosimilars, and injectables mature. Dr Reddys is expanding its manufacturing infrastructure, focusing on high-demand areas like peptide APIs and injectables. It is also poised to capitalise on low-competition injectable launches in the US and growth in emerging markets, including India and Canada. The Canadian semaglutide market, estimated at US $ 1-1.5 billion (bn), offers a significant opportunity post the 2026 patent expiry. The companys ability to transition from near-term challenges to medium and long-term growth is driving investor optimism. Strategic investments, new market opportunities, and innovative initiatives position Dr Reddys for sustained growth, contributing to its recent share price surge. In the past five days, Dr Reddys share price is up 6.9%. In the last month, it has rallied 12.5%. In 2024, so far it has rallied 15.5%. Additionally, it surged 20.6% in the last year. The stock touched its 52-week high of Rs 1,420.2 on 21 August 2024 and a 52-week low of Rs 1,094.9 on 21 December 2023.20 Dec, 2024 06:13 PMStock Market Crash: Nifty Stocks with Positive Returns This Week
Dr Reddys Laboratories was recently upgraded by Nomura, with a price target of ₹1,500 per share. Nomura believes concerns about the high contribution of Revlimid have already been priced in. In the first half of the 2024-25 fiscal year, a large part of the companys growth was driven by initiatives, including clinical trials for biosimilars. The brokerage highlighted that Dr. Reddys Laboratories has significantly increased investments in manufacturing infrastructure, with its capex more than doubling in FY25. Moreover, the potential upside from GLP-1 and biosimilars has not been fully accounted for in FY27 estimates.20 Dec, 2024 04:48 PMIndian Equity Indices End Week Lower: Key Gainers and Losers
The top gainers on the Nifty included Dr. Reddys Laboratories, which surged by 1.49 per cent.20 Dec, 2024 04:12 PMSBI Life Insurance Company Ltd Financials
Index Inclusions
SBI Life Insurance Company Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 55.39% | ||
| Foreign Institutions | 25.19% | 1.94 | |
| Mutual Funds | 12.19% | ||
| Retail Investors | 4.1% | 2.67 | |
| Others | 3.13% |
SBI Life Insurance Company Ltd Key Indicators
SBI Life Insurance Company Ltd Earnings and Dividends
SBI Life Insurance Company Ltd Earnings Results
SBI Life Insurance Company Ltd’s net profit jumped 39.25% since last year same period to ₹529.42Cr in the Q2 2024-2025. On a quarterly growth basis, SBI Life Insurance Company Ltd has generated 1.91% jump in its net profits since last 3-months.
Read More about Earnings ResultsSBI Life Insurance Company Ltd Dividends March,2024
In the quarter ending December 2023, SBI Life Insurance Company Ltd has declared dividend of ₹2.70 - translating a dividend yield of 0.19%.
Read More about Dividends
SBI Life Insurance Company Ltd Technicals Summary
Bearish
Neutral
Bullish
SBI Life Insurance Company Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on SBI Life Insurance Company Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy SBI Life Insurance Company Ltd shares.
SBI Life Insurance Company Ltd (SBILIFE) share price today is ₹1400.6
SBI Life Insurance Company Ltd is listed on NSE
SBI Life Insurance Company Ltd is listed on BSE
- Today’s highest price of SBI Life Insurance Company Ltd is ₹1414.8.
- Today’s lowest price of SBI Life Insurance Company Ltd is ₹1391.1.
Today’s traded volume of SBI Life Insurance Company Ltd(SBILIFE) is 15.43L.
Today’s market capitalisation of SBI Life Insurance Company Ltd(SBILIFE) is ₹140085.9Cr.
| SBI Life Insurance Company Ltd(SBILIFE | Price |
|---|---|
52 Week High | ₹1936 |
52 Week Low | ₹1307.7 |
SBI Life Insurance Company Ltd(SBILIFE) share price is ₹1400.6. It is down -27.65% from its 52 Week High price of ₹1936
SBI Life Insurance Company Ltd(SBILIFE) share price is ₹1400.6. It is up 7.10% from its 52 Week Low price of ₹1307.7
| SBI Life Insurance Company Ltd(SBILIFE | Returns |
|---|---|
1 Day Returns | -5.3% |
1 Month Returns | -4.87% |
3 Month Returns | -26.78% |
1 Year Returns | 0.15% |